Real-world cost avoidance associated with bevacizumab biosimilar adoption in a tertiary public hospital in Ecuador: a cost-minimization and budget impact analysis

Cost Effectiveness and Resource Allocation · Published 2026-07-10 · DOI 10.1186/s12962-026-00799-w

Free full text

Authors (5)

Sara Rodríguez, Carla Arias, María del Carmen Aynaguano, Carol Moreno, David Armas

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Rodríguez, S., Arias, C., Aynaguano, M., et al. (2026). Real-world cost avoidance associated with bevacizumab biosimilar adoption in a tertiary public hospital in Ecuador: a cost-minimization and budget impact analysis. Cost Effectiveness and Resource Allocation. https://doi.org/10.1186/s12962-026-00799-w

Related articles

• Exploring trends of cost-effectiveness thresholds in South Korea: systematic review of pharmacoeconomic evaluations since introduction of the positive list system · Cost Effectiveness and Resource Allocation · 2026 · Same journal
• Economic evaluation of PET-CT in staging and response assessment of patients with diffuse large B-cell lymphoma (DLBCL) in Thailand: a cost-utility analysis · Cost Effectiveness and Resource Allocation · 2026 · Same journal
• How accurate should a precision medical test be to meet cost-effectiveness · Cost Effectiveness and Resource Allocation · 2026 · Same journal
• Financial strain beyond coverage: assessing out-of-pocket costs for dialysis care in chronic kidney disease at a tertiary care centre in Central India · Cost Effectiveness and Resource Allocation · 2026 · Same journal
• Influence of clinical benefit and cost-effectiveness on reimbursement decisions for lung cancer drugs in Spain · Cost Effectiveness and Resource Allocation · 2026 · Same journal
• Ghana’s Diagnosis Related Grouping (G-DRG) tariffs versus hospital charges: implications for inpatient care financing at a secondary hospital in Ghana · Cost Effectiveness and Resource Allocation · 2026 · Same journal
• The impact of hospital bed supply on medical insurance expenditure in China (2011–2024): evidence on Roemer’s Law and threshold effects · Cost Effectiveness and Resource Allocation · 2026 · Same journal
• Economic burden of knee replacement, a case of Bushehr, Iran in 2023–2024 · Cost Effectiveness and Resource Allocation · 2026 · Same journal
• Costs of venovenous extracorporeal membrane oxygenation (VV-ECMO) and its potential contribution to quality-adjusted life years: a mixed-methods study protocol · Cost Effectiveness and Resource Allocation · 2026 · Same journal
• Extended cost-effectiveness analysis in global health systems: a scoping review of geographic gaps and research trends · Cost Effectiveness and Resource Allocation · 2026 · Same journal